STOCK TITAN

DECIBEL CANNABIS CO INC - DBCCF STOCK NEWS

Welcome to our dedicated page for DECIBEL CANNABIS CO news (Ticker: DBCCF), a resource for investors and traders seeking the latest updates and insights on DECIBEL CANNABIS CO stock.

Decibel Cannabis Company Inc. (DBCCF) is a market leader in premium cannabis and extract manufactured products. The company recently sold its brick-and-mortar retail cannabis operations, Prairie Records, to FIKA for $3.0 million. Decibel remains committed to delivering exceptional cannabis brands globally, operating in Canada and beyond. The company's revenue growth, financial results, and strategic decisions highlight its dedication to innovation and product quality.

Rhea-AI Summary

Decibel Cannabis Company has announced the postponement of its annual general meeting originally set for September 1, 2022, to improve shareholder participation. Currently, nearly one-third of shareholders have submitted proxies, with an unusual amount of withheld votes compared to previous meetings. The board believes delaying the meeting will foster better governance and allow for addressing any shareholder concerns. A new meeting date will be announced in the future.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.8%
Tags
none
-
Rhea-AI Summary

Decibel Cannabis Company reported second-quarter financial results for the period ending June 30, 2022, showcasing a record net revenue of $18.6 million, marking an 11% increase from Q1 2022 and a 49% rise from Q2 2021. The company achieved a gross margin of 41% and $3.2 million in adjusted EBITDA, reflecting a 31% growth relative to the previous quarter. Despite a decline in flower sales, derivative sales reached $13 million, driven by expanded distribution and new product launches. The company also reported $1.8 million in cash flow from operations, continuing a positive trend.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2%
Tags
-
Rhea-AI Summary

Decibel Cannabis Company Inc. (DBCCF) announced a strong preliminary outlook for Q2 2022, projecting net revenues between $18.5 million and $19.5 million and Adjusted EBITDA of $3.0 million to $3.5 million. This marks the eighth consecutive quarter of positive Adjusted EBITDA. Growth is driven by strong demand across all product categories, particularly newly launched infused products and vape cartridges. The company also reported significant gross margin improvement due to automation and cost engineering initiatives. Q2 2022 results will be released on August 18, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.48%
Tags
none
Rhea-AI Summary

Decibel Cannabis Company has achieved IMC-G.A.P certification, allowing international export of its cannabis products, marking a significant milestone in expanding its market reach. This certification opens sales channels, particularly in Israel, with initial exports expected in the second half of 2022. The CEO highlighted the international demand for premium cannabis and Decibel's readiness to meet this need. The company operates several production facilities across Canada, known for high-quality cultivars like Qwest and Qwest Reserve, as it seeks to enhance brand recognition globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Decibel Cannabis Company Inc. reported strong first-quarter results for the period ending March 31, 2022, with record net revenue of $16.7 million, representing a 19% increase quarter-over-quarter and a 32% rise year-over-year. The company also achieved a record adjusted EBITDA of $2.5 million, marking a 70% growth from the previous quarter. Despite a seasonally weak quarter, Decibel saw increased demand for its new infused pre-rolls and other cannabis products. The company successfully repaid convertible debentures, thereby reducing potential shareholder dilution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.82%
Tags
none
-
Rhea-AI Summary

Decibel Cannabis Company will release its 2022 first quarter financial results on May 25, 2022, before market opening. The company is recognized for its premium cannabis products and operates several production houses across Canada. Notable facilities include the Qwest Estate in Creston, BC, and Thunderchild Cultivation in Battleford, SK, contributing to the brands Qwest and Qwest Reserve. Decibel also emphasizes innovation through its extraction facility in Calgary, which supports a range of new product formats.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.64%
Tags
none
Rhea-AI Summary

On May 11, 2022, Decibel Cannabis Company announced the full cash repayment of its 9.5% convertible debentures, totaling $12 million, which matured on May 10, 2022. The repayment was made possible by a simultaneous draw-down of $12 million from its credit facility with ConnectFirst Credit Union, which carries a fixed interest rate of 4.75% per annum, repayable over 60 months. Decibel continues to focus on producing high-quality cannabis products through its various facilities in Canada.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.69%
Tags
none
-
Rhea-AI Summary

Decibel Cannabis Company (DBCCF) has reported strong financial results for the year ending December 31, 2021, achieving a net revenue of $52 million, a 75% increase from 2020. The gross profit rose by 53% to $18 million, with an impressive adjusted EBITDA of $7.4 million, marking a 386% increase. In Q4 alone, net revenue reached $14 million, up 5% from the previous quarter. Despite facing price compression and increased competition, Decibel anticipates net revenue of $16.5 - $17.5 million for Q1 2022, and a national market share of 4.0%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.98%
Tags
none
-
Rhea-AI Summary

Decibel Cannabis Company (TSXV: DB; OTCQB: DBCCF) will announce its 2021 fourth quarter financial results on April 22, 2022, before market opening. The announcement will include a management discussion and analysis of the financial outcomes. Decibel operates multiple production facilities in Canada, producing high-quality cannabis products and retail experiences through its brands like Qwest, Qwest Reserve, and Prairie Records.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.13%
Tags
none
Rhea-AI Summary

Decibel Cannabis Company has appointed Manjit Minhas as a Senior Advisor to its Board of Directors, pending her nomination as a director at the upcoming shareholder meeting in June 2022. Minhas brings extensive expertise in consumer packaged goods and cannabis, having co-founded Minhas Brewery and served on the board of Inner Spirit Holdings Ltd. Decibel aims to leverage her experience to strengthen its board and enhance its product offerings across various formats.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.65%
Tags
management

FAQ

What is the current stock price of DECIBEL CANNABIS CO (DBCCF)?

The current stock price of DECIBEL CANNABIS CO (DBCCF) is $0.0527 as of January 21, 2025.

What is the market cap of DECIBEL CANNABIS CO (DBCCF)?

The market cap of DECIBEL CANNABIS CO (DBCCF) is approximately 30.3M.

What is Decibel Cannabis Company Inc. known for?

Decibel Cannabis Company Inc. is a market leader in premium cannabis and extract manufactured products, known for delivering exceptional cannabis brands globally.

What recent transaction did Decibel Cannabis Company Inc. complete?

Decibel recently closed the sale of its brick-and-mortar retail cannabis operations, Prairie Records, to FIKA for approximately $3.0 million.

Where does Decibel Cannabis Company Inc. operate?

Decibel operates in Canada and is expanding globally, focusing on delivering innovative and high-quality cannabis products to customers.

What is the strategic focus of Decibel Cannabis Company Inc.?

Decibel's core focus lies in driving innovation, product quality, and expanding its premium cannabis brand portfolio in Canada and worldwide.

Who is Adam Coates at Decibel Cannabis Company Inc.?

Adam Coates serves as the Chief Revenue Officer at Decibel Cannabis Company Inc., emphasizing the strategic growth journey and commitment to delivering exceptional cannabis brands.
DECIBEL CANNABIS CO INC

OTC:DBCCF

DBCCF Rankings

DBCCF Stock Data

30.28M
431.53M
23.73%
0.17%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Calgary